Concepedia

Evaluation of PD-L1 Expression Level in Patients With Non-Small Cell Lung Cancer by 18F-FDG PET/CT Radiomics and Clinicopathological Characteristics

Jihui Li, Shushan Ge, Shibiao Sang, Chunhong Hu, Shengming Deng

Frontiers in Oncology · 2021 · 62 citations · 23 references

DOIFull text

Open access

Abstract

A prediction model based on PET/CT images and clinicopathological characteristics provided a novel strategy for clinicians to screen the NSCLC patients who could benefit from the anti-PD-L1 immunotherapy.

References

23

Radiomics: Images Are More than Pictures, They Are Data

Robert J. Gillies, Paul E. Kinahan, Hedvig Hricak · Radiology · 2015 · 7.9K citations

, , +16

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Julie R. Brahmer, Scott S. Tykodi, Laura Q.M. Chow et al. · New England Journal of Medicine · 2012 · 7.9K citations · Full text

THE LASSO METHOD FOR VARIABLE SELECTION IN THE COX MODEL

Robert Tibshirani · Statistics in Medicine · 1997 · 4.2K citations

PD-L1 Expression in Triple-Negative Breast Cancer

Elizabeth A. Mittendorf, Anne V. Philips, Funda Meric‐Bernstam et al. · Cancer Immunology Research · 2014 · 1.4K citations · Full text

, , +14

A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study

Roger Sun, Elaine Johanna Limkin, Maria Vakalopoulou et al. · The Lancet Oncology · 2018 · 1.2K citations

, , +11